<--- Back to Details
First PageDocument Content
Tropics / Antibiotics / Sulfones / Clofazimine / Phenazines / Leprostatic agent / Dapsone / Erythema nodosum / Rifampicin / Medicine / Leprosy / Health
Date: 2009-03-31 16:04:27
Tropics
Antibiotics
Sulfones
Clofazimine
Phenazines
Leprostatic agent
Dapsone
Erythema nodosum
Rifampicin
Medicine
Leprosy
Health

NDA[removed]S-010 Page 3

Add to Reading List

Source URL: www.accessdata.fda.gov

Download Document from Source Website

File Size: 161,37 KB

Share Document on Facebook

Similar Documents

Chemistry / Organic chemistry / Sulfones / Dapsone / Clofazimine / Rifampicin / Leprostatic agent / Antimalarial medication / Dermatitis herpetiformis / Medicine / Leprosy / Antibiotics

Australian Product information Dapsone  NAME OF THE DRUG:  Dapsone  DESCRIPTION: 

DocID: ZVvB - View Document

Bacterial diseases / Leprosy / Epidemiology / Methicillin-resistant Staphylococcus aureus / Epidemiology of leprosy / Measles / Tuberculosis / Leprostatic agent / Microbiology / Medicine / Health

Communicable Diseases Watch

DocID: Tt1X - View Document

Bacterial diseases / Leprosy / Epidemiology / Methicillin-resistant Staphylococcus aureus / Epidemiology of leprosy / Measles / Tuberculosis / Leprostatic agent / Microbiology / Medicine / Health

Communicable Diseases Watch

DocID: SwYs - View Document

Tropics / Dapsone / Mycobacterium leprae / Borderline lepromatous leprosy / Leprostatic agent / WHO Expert Committee on Leprosy / Leprosy / Microbiology / Medicine

Leprosy: A Case to Recognize Learning Objectives: The objective of this study was to highlight a pediatric case of leprosy diagnosed recently at The Hospital for Sick Children and review the literature on the diagnosis a

DocID: uq05 - View Document

Bacteria / Bacterial diseases / Corynebacterineae / Mycobacterium leprae / Tuberculoid leprosy / Disease / Pathogenic bacteria / Leprostatic agent / Lepromin / Microbiology / Medicine / Leprosy

Guide to Surveillance, Reporting and Control[removed]Massachusetts Department of Public Health, Bureau of Communicable Disease Control

DocID: pwmI - View Document